CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 05/07/2025 | 10.17 M | $345.93 M | 13.29% | 11.83% |
| CAPITAL INTERNATIONAL INVESTORS | 05/12/2025 | 6.07 M | $206.67 M | -30.54% | 7.07% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 3.80 M | $129.25 M | -0.36% | 4.42% |
| BLACKROCK, INC. | 05/02/2025 | 2.61 M | $88.94 M | -5.28% | 3.04% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/25/2025 | 2.54 M | $86.43 M | -7.49% | 2.96% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2025 | 2.54 M | $86.33 M | -7.49% | 2.96% |
| STATE STREET CORP | 05/15/2025 | 2.41 M | $82.06 M | -3.22% | 2.81% |
| UBS GROUP AG | 05/13/2025 | 2.07 M | $70.51 M | 4.43% | 2.41% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 1.95 M | $66.45 M | 182.93% | 2.27% |
| FMR LLC | 05/12/2025 | 1.94 M | $66.04 M | -12.72% | 2.26% |
| VANGUARD GROUP INC | 05/09/2025 | 1.77 M | $60.22 M | 1.94% | 2.06% |
| NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 1.59 M | $54.03 M | 0.00% | 1.85% |
| ORBIS ALLAN GRAY LTD | 05/15/2025 | 1.56 M | $53.19 M | 5.88% | 1.82% |
| ECOR1 CAPITAL, LLC | 05/15/2025 | 1.39 M | $47.28 M | 0.00% | 1.62% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.39 M | $47.19 M | 14.47% | 1.61% |
| MORGAN STANLEY | 05/15/2025 | 1.30 M | $44.24 M | 162.62% | 1.51% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 1.19 M | $40.47 M | 288.27% | 1.38% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/13/2025 | 1.05 M | $35.70 M | 0.00% | 1.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.05 M | $35.61 M | 4.50% | 1.22% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 937.15 K | $31.90 M | -1.07% | 1.09% |
| LOOMIS SAYLES & CO L P | 05/14/2025 | 909.79 K | $30.96 M | -0.13% | 1.06% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 797.20 K | $27.13 M | 840.09% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 713.54 K | $24.28 M | -1.31% | 0.83% |
| BAKER BROS. ADVISORS LP | 05/15/2025 | 654.10 K | $22.26 M | -49.99% | 0.76% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 583.73 K | $19.86 M | 6,769.06% | 0.68% |
| VERSANT VENTURE MANAGEMENT, LLC | 05/07/2025 | 498.56 K | $16.97 M | 0.00% | 0.58% |
| PEAK6 LLC | 05/14/2025 | 478.00 K | $16.27 M | 3,414.71% | 0.56% |
| CITADEL ADVISORS LLC | 05/15/2025 | 425.50 K | $14.48 M | 45.57% | 0.50% |
| CITADEL ADVISORS LLC | 05/15/2025 | 412.70 K | $14.04 M | -48.00% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 408.60 K | $13.90 M | -23.57% | 0.48% |
| MARSHALL WACE, LLP | 05/15/2025 | 393.30 K | $13.38 M | 100.00% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 343.40 K | $11.69 M | 107.74% | 0.40% |
| 05/12/2025 | 331.97 K | $11.30 M | -9.99% | 0.39% | |
| PEAK6 LLC | 05/14/2025 | 323.70 K | $11.02 M | 339.81% | 0.38% |
| CAPITAL ADVISORS INC/OK | 04/29/2025 | 307.50 K | $10.46 M | -0.89% | 0.36% |
| JPMORGAN CHASE & CO | 05/12/2025 | 295.99 K | $10.07 M | 2.36% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 291.02 K | $9.90 M | -25.06% | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 266.50 K | $9.07 M | 0.00% | 0.31% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 265.53 K | $9.04 M | 20.63% | 0.31% |
| CITADEL ADVISORS LLC | 05/15/2025 | 257.55 K | $8.76 M | -70.70% | 0.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 246.09 K | $9.07 M | -9.76% | 0.29% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 242.32 K | $8.25 M | 0.78% | 0.28% |
| NORTHERN TRUST CORP | 05/13/2025 | 237.65 K | $8.09 M | -7.59% | 0.28% |
| JANE STREET GROUP, LLC | 05/19/2025 | 237.13 K | $8.07 M | -44.44% | 0.28% |
| JANE STREET GROUP, LLC | 05/19/2025 | 230.80 K | $7.85 M | 107.93% | 0.27% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 05/13/2025 | 225.31 K | $7.67 M | -7.67% | 0.26% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 218.06 K | $7.42 M | 6.28% | 0.25% |
| CITIGROUP INC | 05/12/2025 | 205.65 K | $7.00 M | 86.35% | 0.24% |
| LPL FINANCIAL LLC | 05/07/2025 | 185.46 K | $6.31 M | 23.86% | 0.22% |
| JANE STREET GROUP, LLC | 05/19/2025 | 170.40 K | $5.80 M | 264.10% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 337 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
OGOREK ANTHONY JOSEPH /NY/ /ADV: 0
Stone House Investment Management, LLC: 0
Frazier Financial Advisors, LLC: 0
Global Financial Private Client, LLC: 0
FOX RUN MANAGEMENT, L.L.C.: 0
Golden State Wealth Management, LLC: 0
74.67% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 51.23 M shares in the last 24 months. This purchase volume represents approximately $2.90 B in transactions.